Dr. Chiang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4647 Zion Ave
San Diego, CA 92120Phone+1 619-528-5000- Is this information wrong?
Education & Training
University of Southern California/LAC+USC Medical CenterResidency, Emergency Medicine, 1995 - 1999
New York Medical CollegeClass of 1995
Certifications & Licensure
CA State Medical License 1997 - 2024- American Board of Emergency Medicine Emergency Medicine
Clinical Trials
- Alopecia Areata Registry Start of enrollment: 2001 Nov 01
- Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis Start of enrollment: 2008 Oct 01
Publications & Presentations
PubMed
- 35 citationsTopical steroid risk analysis: Differentiating between physiologic and pathologic adrenal suppressionEthan Levin, Rishu Gupta, Daniel C. Butler, Charles Chiang, John Koo> ;The Journal of Dermatological Treatment. 2014 Jan 10
- Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study.Tina Bhutani, Faranak Kamangar, Kristine B Zitelli, Charles Chiang, Shilpa Gattu, Thao Nguyen, Emily M. Becker, John Koo> ;The Journal of Dermatological Treatment. 2013 Oct 1
- 2 citationsPsoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: Interim results of a single-arm, open-label s...Shilpa Gattu, Kristine Busse, Tina Bhutani, Charles Chiang, Thao Nguyen, Emily M. Becker, John Koo> ;The Journal of Dermatological Treatment. 2012 Mar 12
- Join now to see all
Hospital Affiliations
Kaiser Permanente San Diego Medical CenterSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
